| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |